Literature DB >> 17602106

Validation and application of a radioimmunoassay for ovine growth hormone in the diagnosis of acromegaly in cats.

S J M Niessen1, M Khalid, G Petrie, D B Church.   

Abstract

The validity of an ovine growth hormone (OGH) assay for the detection of feline growth hormone (FGH) was demonstrated by the parallel displacement of radiolabelled OGH by standard concentrations of OGH and serial dilutions of pooled FGH-rich serum. The minimum detectable limit of the assay was 1.67 microg/l. The mean (sd) basal fasting FGH level in 19 non-acromegalic, non-diabetic cats aged two to 16 years was 4.01 (1.38) microg/l (range 1.87 to 6.33); 19 acromegalic cats had significantly higher FGH levels (range 8.45 to 33.2 microg/l). There were no significant differences in the FGH levels measured when aprotinin was added to the samples or when plain serum and serum gel separation tubes were used for blood collection, but the FGH levels were significantly higher when the samples were collected into EDTA. There were also no significant differences between the concentrations of FGH measured in samples in which the separation of the serum and storage had been delayed by 24 hours, or in samples that had been stored for up to four weeks at -20 degrees C.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17602106     DOI: 10.1136/vr.160.26.902

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  8 in total

1.  Studying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter.

Authors:  Stijn J M Niessen; Yaiza Forcada; Panagiotis Mantis; Christopher R Lamb; Norelene Harrington; Rob Fowkes; Márta Korbonits; Ken Smith; David B Church
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

2.  Pasireotide for the Medical Management of Feline Hypersomatotropism.

Authors:  C J Scudder; R Gostelow; Y Forcada; H A Schmid; D Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2015-05-06       Impact factor: 3.333

3.  Evaluation and diagnostic potential of serum ghrelin in feline hypersomatotropism and diabetes mellitus.

Authors:  K B Jensen; Y Forcada; D B Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2015-01       Impact factor: 3.333

4.  Hypersomatotropism in 3 Cats without Concurrent Diabetes Mellitus.

Authors:  J M Fletcher; C J Scudder; M Kiupel; H N Pipe-Martin; P J Kenny; P Mantis; J Fenn; K Smith; R V Blair; L A Granger; S J M Niessen
Journal:  J Vet Intern Med       Date:  2016-06-03       Impact factor: 3.333

5.  Serum N-Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism.

Authors:  S V Keyte; P J Kenny; Y Forcada; D B Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2016-07-18       Impact factor: 3.333

6.  Associations among echocardiography, cardiac biomarkers, insulin metabolism, morphology, and inflammation in cats with asymptomatic hypertrophic cardiomyopathy.

Authors:  Ingrid van Hoek; Hannah Hodgkiss-Geere; Elizabeth F Bode; Julie Hamilton-Elliott; Paul Mõtsküla; Valentina Palermo; Yolanda M Pereira; Geoff J Culshaw; Anna Ivanova; Jo Dukes-McEwan
Journal:  J Vet Intern Med       Date:  2020-02-11       Impact factor: 3.333

7.  Efficacy of hypophysectomy for the treatment of hypersomatotropism-induced diabetes mellitus in 68 cats.

Authors:  Joe Fenn; Patrick J Kenny; Christopher J Scudder; Katarina Hazuchova; Ruth Gostelow; Robert C Fowkes; Yaiza Forcada; David B Church; Stijn J M Niessen
Journal:  J Vet Intern Med       Date:  2021-02-24       Impact factor: 3.333

8.  Evaluation of hypophysectomy for treatment of hypersomatotropism in 25 cats.

Authors:  Kirsten L van Bokhorst; Sara Galac; Hans S Kooistra; Chiara Valtolina; Federico Fracassi; Dan Rosenberg; Björn P Meij
Journal:  J Vet Intern Med       Date:  2021-02-23       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.